Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Heart Polypill in Primary Prevention of Cardiovascular Disease - Safety and Efficacy

NCT00603590 is registered in ClinicalTrials.gov with Tehran University of Medical Sciences as lead sponsor.

NCT NCT00603590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00603590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Heart Polypill in Primary Prevention of Cardiovascular Disease - Safety and Efficacy
Lead sponsor
Tehran University of Medical Sciences
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2006
Completion date
July 31, 2008
Enrollment
475 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, heart disease, hyperlipidemia, hypertension